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Somatostatin antagonizes angiotensin II effects on mesangial cell con-
traction and glomerular filtration. The effects of somatostatin (ST) on
the regulation of the glomerular filtration rate have not been extensively
studied. The present experiments were designed to analyze this possi-
ble relationship. ST alone did not modify the planar cell surface area
(PCSA) of cultured rat mesangial cells (CRMC), but it prevented and
reversed the reduction in PCSA induced by 10 nri angiotensin II (Ang
H) in a dose- and time-dependent manner. ST (1 sM) completely
prevented and reversed the increase in the myosin light chain phos-
phorylation induced by 10 flM Ang II. Incubation with pertussis toxin
(PT, 0.5 sg/ml) inhibited the effect of ST on the Ang Il-dependent
changes in PCSA, but this effect was not inhibited by the blockade of
the vasodilatatory prostaglandins (indomethacin, 10 sM) or nitric oxide
(L-N-methyl-arginine, 0.2 mM) synthesis. 2' ,5'-dideoxyadenosine
(DDA, 0.1 mM), an adenylate cyclase blocker, and methylene blue
(MB, 30 LM), a soluble guanylate cyclase blocker, did not interfere with
the ST inhibitory effect on the Ang LI-dependent reduction in PCSA of
rat mesangial cells. ST also blocked the reduction in PCSA induced by
phorbol myristate acetate (PMA, 300 nM). ST was also able to prevent
and revert the Ang II dependent reduction in glomerular cross-sectional
area of isolated rat glomeruli, also in a dose- and time-dependent
fashion. Finally, intravenous administration of ST (200 nglkg body wt as
a bolus plus a continuous injection of 25 ng/min/kg body wt) partially
blocked the reduction in GFR (measured as C1,,) and RPF (measured as
CPAH) and the increase in filtration fraction induced by the intravenous
administration of Ang 11(1.7 g/minfkg body wt) in anesthetized rats. In
summary, these results suggest that ST could antagonize the renal
actions of Ang II, increasing the GFR and RPF decreased by Ang II,
and this effect could be dependent, at least partially, on a direct relaxing
effect of ST on mesangial cells.
The information available at the present moment about the
renal actions of somatostatin (ST) is scarce [1]. Specific ST
binding sites have been found in renal cortex and medulla [2]
and it is usually accepted that ST antagonizes the effects of
arginine vasopressin on water permeability in collecting ducts
and toad urinary bladder [3—5]. It seems that this effect could be
mediated by a direct modulation of adenylate cyclase activity
[6, 7]. Moreover, ST may inhibit the diuretic-induced renin
release [8]. On the other hand, the information concerning the
possible regulation of glomerular filtration rate (GFR) or renal
plasma flow (RPF) by ST is controversial. Intravenous infusion
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of ST in the cat reduces renal vascular resistance [9] but
increases it in the dog [10]. In the human, it seems to decrease
renal perfusion [11] besides inducing a transient increase in
blood pressure and a reduction in splanchnic blood flow [12].
This lack of definitive conclusions could be due to the difficult
interpretation of the results obtained with systemic infusion of
ST or even with intrarenal administration. For instance, in
addition to its intrinsic renal actions, ST could modulate the
systemic synthesis of some vasoactive substances such as
glucagon or GH [13, 14], thus interfering with the interpretation
of the renal results. In addition, the effects of ST on the
regulation of GFR and RPF may not be the same in different
physiological conditions. It is possible that the renal actions of
ST could differ in basal conditions or under renin-angiotensin
system or vasopressin stimulation. In fact, it has been described
that ST antagonizes angiotensin II effects on the adrenal gland
[1], and it would not be surprising that the ST inhibitory effect
on vasopressin could also occur in other non-tubular structures.
Thus, the present experiments were designed in order to
clarify, in an approach including in vitro and in vivo experi-
ments, the possible role of ST as a modulator of glomerular
filtration, mainly in the presence of an Ang II excess, in an
attempt to explain the intrinsic mechanisms of action of this
hormone.
Methods
Materials
Collagenase type IA, from Clostridium hisriolyticum, angio-
tensin II, phorbol myristate acetate, pertussis toxin, indometha-
ci L-N-methyl-arginine, methylene blue, L-glutamine, myo-
sin light chain standard, and myosin light chain monoclonal
antibody (specific against 20 kD myosin light chains) were
purchased from Sigma (St. Louis, Missouri, USA). Alkaline
phosphatase-linked rabbit anti-mouse IgG serum and 5-bromo-
4-chloro-3-indolyl phosphate/nitroblue tetrazolium (BCIP/
NBT) were from Bio-Rad (Richmond, California, USA). Peni-
cillin was obtained from Laboratorios Level SA (Barcelona,
Spain). Streptomycin sulfate was obtained from Antibioticos
SA (Madrid, Spain). RPMI 1640, Hanks balanced salt solution
and fetal calf serum were obtained from Flow Laboratories
(Woodcock Hill, UK). 2',5'-dideoxyadenosine and SDS-PAGE
electrophoresis standards for molecular weight were from Phar-
macia (Uppsala, Sweden). [32P] orthophosphoric acid (HCI
free) was from Amersham International (Buckinghamshire,
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UK). Somatostatin (cyclic 14-28) was a gift from Serono S.A.
(Madrid, Spain). All the other reagents were of the highest
commercially available grade.
Fig. 1. Somatostatin prevents the changes induced by angiotensin II in
planar cell surface area (PCSA) of cultured rat mesangial cells. Results
are expressed as percent of the PCSA at time 0 and are the mean SEM
of 5 experiments. Abbreviations are: C, cells with buffer; Ang II, cells
with angiotensin II; ST, cells with somatostatin. A. ST + Ang II: cells
were preincubated for 10 minutes with 1 /LM somatostatin (ST) and then
(time 0)10 nM angiotensin II (Ang II) added. *D < 0.05 vs. C, ST and
ST + Ang II. B. Cells were preincubated for 10 minutes with different
ST concentrations and then 10 nM Ang II for 30 minutes added. *P <
0.05 vs. Ang II.
Glomerular isolation and mesangial cell culture
Renal glomeruli were isolated from Wistar rats weighing 150
to 200 g. Kidneys were removed under ether anesthesia and
glomeruli isolated by successive mechanical sieving (105 and 75
m) [15, 16]. The final preparation consisted of glomeruli
without Bowman's capsule and afferent or efferent arterioles.
Tubular contamination was less than 5%. Buffer A (Tris 20 m,
NaC1 130 mt, KCI 5 m, sodium acetate 10 m, glucose 5 mM,
pH 7.45) was used in all the steps of the isolation procedure.
40 Isolated glomeruli obtained by a similar mechanical sieving
procedure (150 and 50 m) from rats weighing 100 to 150 g were
treated with collagenase, plated in plastic culture flasks and
incubated as previously described [17, 18]. The culture medium
consisted of RPM! 1640 supplemented with 10% fetal calf
serum, L-glutamine (1 mM), penicillin (0.66 tg/ml), streptomy-
cm sulfate (60 g/ml), and buffered with Hepes, pH 7.2. Culture
media were changed every two days. Studies were performed
on day 21 or 22, at which time epithelial cells were no longer
detected in the culture flasks. The identity of the cells was
confirmed by morphological and functional criteria [17, 18].
Incubation procedures for microphotograph experiments
In every experiment, cells or glomeruli were washed twice,
discarding the culture or isolation media and placed in fresh
buffer A containing 2.5 mri Ca2 and maintained at room
temperature. After 15 minutes in these conditions, experiments
were started.
In the first set of experiments, cells or glomeruli were
preincubated for 10 minutes with buffer or 1 tM somatostatin
(ST) and, after this time, 10 flM Ang II was added to the
incubation media. Microphotographs were taken just before
Ang II addition and after 30 minutes of incubation. Control cells
or glomeruli, incubated only with buffer, were used in each
case. Thereafter, the same experiments were performed but
using different final concentrations of ST (10— 10 to 106 M).
In the second set of experiments, cells or glomeruli were
incubated for 30 minutes with buffer or 10 flM Ang II. Then, ST
was added to the incubation media, at a final concentration of 1
tM and microphotographs were taken just before the addition
of buffer or Ang II (time 0), immediately before the ST (time 30)
and 30 minutes after the ST (time 60). Incubations performed
only with buffer, ST or Ang II were used as controls. The same
experiments were again performed in the presence of different
concentrations of ST (final concentrations 10b0 to lO_6 M).
Microphotographs were also performed in the presence of
some pharmacological modulators, always with the same ex-
perimental design. After 15 minutes of incubation with a spe-
cific drug, 1 M ST was added to the incubation media for 10
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minutes and then 10 nM Ang II was also added. Microphoto-
graphs were taken just before Ang II addition and 30 minutes
later. The drugs and their final concentrations were as follows:
indomethacin (I, 10 p.M), L-N-methyl-arginine (LNMA, 0.2
mM), 2',S'-dideoxyadenosine (DDA, 0.1 mM) and methylene
blue (MB, 30 JiM). Pertussis toxin (PT) was also used in some
experiments, but the preincubation time was 18 hours, and the
PT concentration was 0.5 Jig/mI.
Finally, cells were preincubated for 10 minutes with buffer or
1 JiM somatostatin (ST) and then either 300 nM phorbol
myristate acetate (PMA) or 100 JiM H202 was added to the
incubation media. Microphotographs were taken just before
PMA or H202 addition and after 30 minutes of incubation.
Control cells, incubated only with buffer, were used in each
case.
The ability of cells to exclude the trypan blue dye was tested
in the different experimental conditions mentioned above.
Determination of planar cell surface area (PCSA) and
glomerular cross-sectional area (GCSA)
While incubations were performed, mesangial cells grown in
conventional plastic culture flasks, or samples of 100 d of
glomerular suspensions on excavated glass slides, maintained at
room temperature (22 2°C), were observed under phase
contrast with an inverted photomicroscope Olympus IMT 2
(Shibuya-Hu, Tokyo, Japan) with a 150 magnification [15—18].
Serial photographs were taken under the experimental condi-
tions cited above. Seven to 16 cells and 30 to 50 glomeruli were
analyzed per photograph. No specific selection criteria existed:
every cell or glomeruli which could be measured was analyzed.
PCSA and GCSA were determined by computer-aided plani-
metric techniques. Measurements were performed by two dif-
ferent investigators in a blind fashion. The intraobserver and
interobserver variations for cells and glomeruli were 2 and 5%
(cells) and 1 and 3% (glomeruli), respectively.
Phosphorylation of myosin light chain
Measurement of myosin light chain (MLC) phosphorylation
was performed as described [19], with minor modifications [20].
Rat mesangial cells grown on standard culture flasks were
preincubated for three hours at 37°C in Tyrode's solution
containing 50 sCi/ml of carrier-free [32P] orthophosphoric acid
(HC1 free). Afterwards, cells maintained at room temperature
were incubated with 1 JiM ST for 10 minutes, followed by 10 nM
Ang II for 30 minutes. In the other group of experiments, cells
labeled with [32P] orthophosphoric acid were incubated with 10
nM Ang II for 30 minutes at room temperature; ST (1 JiM, 30
mm) was then added. Control cells were incubated in Tyrode's
solution under the same experimental conditions. Following the
incubations, the medium was siphoned off and the total protein
was precipitated directly on the culture flask by adding I ml of
2% TCA. This was followed by washes with 1 ml of 2% TCA
A
Fig. 2. Somatostatin reverses the changes induced by angiotensin II in
planar cell surface area (PCSA) of cultured rat mesangial cell. Results
are expressed as percent of the PCSA at time 0 and they are the mean
SEM of 5 experiments. Abbreviations are: C, cells with buffer; Ang II,
cells with angiotensin II; ST, cells with somatostatin. A. Ang II + ST:
Cells were incubated for 30 minutes with 10 nM angiotensin II (Ang II)
and then 1 LM somatostatin (ST) added for 30 minutes. *D < 0.05 vs. C
and ST. **P < 0.05 vs. C, ST and Ang II -I- ST. B. Cells incubated for
30 minutes with 10 nM Ang II and then different ST concentrations
added for 30 minutes. < 0.05 vs. Ang II.
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Fig. 3. Morphological changes in
cultured rat mesangial cells. A. Cells
in basal conditions. B. Cells after 30
minutes of incubation with 10 nsi Ang
II. C. The same cells as in B but after
30 minutes of incubation with I M
ST. Notice especially the cells
marked with the arrows.
and 1 ml of water containing 0.2 mM ethylenediaminetetra-
acetic acid (EDTA) and 0.1 j.tg/ml phenylmethylsulfonyl fluo-
ride (PMSF). Precipitated protein was dissolved in 200 d of gel
electrophoresis buffer [2% SDS, 10% (vol/vol) glycerol, 5%
2-mercaptoethanol, and 0.002% bromophenol blue, pH 8.8].
The samples were heated for three minutes in boiling water and
electrophoresed. Protein concentrations of each sample were
also determined [21]. The following marker proteins were
electrophoresed: lactalbumin, 14,400; trypsin inhibitor, 20,100;
carbonic anhydrase, 30,000; ovalbumin, 43,000; albumin,
67,000; and phosphorylase b, 94,000. In addition, a MLC
standard was also electrophoresed.
Samples of 30 pA were electrophoresed on 5 to 30% gradient
polyacrylamide gels using continuous buffer system (150 V, 3 to
4 hours). Gels were stained for three hours in a solution
containing 0.5% copper sulfate, 1.5% Coomassie blue (R-250),
10% acetic acid, 23% methanol. The gels were destained in a
0.5% copper sulfate, 10% acetic acid, 25% methanol solution.
The phosphorylated 20,000 dalton protein which comigrates
with the MLC standard was located. A slice containing all of the
radioactivity was cut from the gel and solubilized in 30% H202
at 70°C for one hour. The radioactivity was quantitated by
liquid scintillation spectrometry and corrected for the total
protein electrophoresed.
To confirm the results obtained, labeled cellular proteins,
prepared and separated as described above (SDS-PAGE), were
transferred onto nitrocellulose filters in a buffer containing 25
mM Tris, 192 mivi glycine, 20% vollvol methanol, pH 8.3, with
application of 250 mA for two hours at 4°C. The nitrocellulose
paper was incubated for two hours with the myosin light chain
monoclonal antibody, diluted 1/200, followed by incubation
with alkaline phosphatase-linked rabbit anti-mouse IgG serum.
The immunostained bands were visualized after incubation with
BCIP/NBT. Autoradiograms were obtained of the bands spe-
cifically immunostained. Then, these bands were cut (dupli-
cates), the nitrocellulose was dissolved with formic acid and the
radioactivity was measured, correcting the value for the total
protein content.
Studies of renal function in anesthetized rats
Clearance studies were performed in 36 male Wistar rats
weighing 300 to 350 g. Animals were anesthetized with sodium
pentobarbital (40 mg/kg body wt) and surgically prepared for
clearance studies [22] by inserting polyethylene catheters (PE
50, Vygon, France) in the femoral artery and vein and in the
bladder, after tracheostomy. All the surgical wounds were
covered with warm, saline moistened gauzes. The femoral
artery catheter was connected to a pressure transducer (EM
750, Lectromed, UK) and the pressure was continuously reg-
istered with a polygraph (Uni-Graph 1000-506, Letica). An
isotonic saline infusion containing [metoxi-14C] inulin and [3H]
para-aminohippuric acid was started at 1.2 ml/hr through the
venous catheter to allow clearance determinations. After 45
minutes of equilibration, three 20-minute urine collections were
performed into preweighed plastic vials containing 0.25 ml
water-stabilized mineral oil, taking 100 pA blood samples at the
beginning and the end of each 20 minute period in heparinized
microhematocrit tubes. Then, rats were divided in three groups
of 12 animals each: the first one received just the 1.2 mllmin
saline infusion, the second one was continuously injected with
1.7 tgImin/kg body wt Ang II in addition to the saline injection,
and the third one received the same amount of saline infusion
and Ang II; after 40 minutes, the third one was treated with a
200 ng/kg body wt ST bolus plus a continuous injection of 25
ng!min/kg body wt ST. In these conditions, three additional
20-minute clearance periods were performed. After measuring
blood hematocrit, plasma and urine concentrations of [metoxi-
'4C] inulin and [3H] para-aminohippuric acid were measured
with a two-channel scintillation counter, which corrects cross-
talk between isotopes.
Statistical methods
Results are expressed as X SEM and the number of
experiments is shown in every case. Comparisons were per-
formed by the paired or unpaired Student's t-test, one- or
two-way analysis of variance, Scheffe's multiple comparison
A B C
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Prevention Reversion
30 mm 30 mm 60 mm
C
Ang II
ST
ST-Ang II
5±146 46±38 4
C
Ang II
ST
Ang lI-ST
4±244 3
7±345 3
7±4
45 3a
10±4
14 3
Data are expressed in % of contracted cells with respect to the total
cells measured and are the mean SEM of 5 experiments. A
contraction was considered significant when the changes in PCSA were
over 8%. Prevention: ST was added before Ang II, Reversion: ST was
added after Ang II. Abbreviations are: C, cells with buffer only; Ang II,
angiotensin 1110 nM; ST, somatostatin I /LM; ST-Ang II, cells preincu-
bated for 10 minutes with ST I LM and then Ang 1110 n was added;
Ang Il-ST. cells incubated for 30 minutes with Ang 1110 nM and then ST
1 tM was added.
a P < 0.05 vs. the other groups, at the same time
test and Friedman test as needed. A P < 0.05 was considered
statistically significant.
Results
Figure 1 shows the consequences of the ST pretreatment on
the changes in PCSA induced by Ang II. ST 1 /LM alone did not
modify the PCSA of cultured mesangial cells but completely
blocked the 25 to 30% reduction in PCSA induced by 10 nM Ang
II (Fig. 1A). As shown in Figure 1B, this inhibition seemed to be
dose-dependent, with a threshold effect at a ST concentration of
10 nM and a maximum effect of 1 M. Results were completely
comparable when ST was added to the cell incubation media
after 30 minutes with 10 tiM Ang II: 1 M ST completely
reversed the Ang II dependent changes in PCSA (Fig. 2A) and
this inhibition was also dose-dependent, with a significant
blockade from 10 nM ST (Fig. 2B). This ability of ST to reverse
the Ang 11-induced mesangial cell contraction is further docu-
mented in Figure 3. The left panel (A) of this figure shows the
mesangial cells in basal conditions. Notice particularly the cells
marked with the arrows. After 30 minutes with 10 flM Ang II,
the PCSA of these cells decreased significantly (B, central
panel), whereas after 30 minutes of the addition of 1 /LM ST
PCSA increased again and the cells tended to recover their
original form (C, right panel). Table 1 performs a similar
analysis but considering the percentage of contracted cells. As
the interobserver variability in the cell measurement was about
5%, it was considered that a cell showed a contraction when the
change in PCSA with respect to the basal situation was over
Fig. 4. Modulation of myosin light chain (MLC) phosphorylation(MLCP) by angiotensin II and somatostatin in cultured rat mesangial
cells. Results are expressed as percent of the control cell MLCP from
the same day of the study and are the mean SEM of 4 experiments.
Abbreviations are: C, cells with buffer; Ang II, cells with angiotensin II;
B. ST, cells with somatostatin. A. ST-Ang II: Cells preincubated for 10
minutes with 1 tLM somatostatin (ST) and then 10 flM angiotensin II
(Ang II) added for 30 minutes. Ang II + ST: Cells incubated for 30
minutes with 10 nM angiotensin II (Ang II) and then I M somatostatin
(ST) added for 30 minutes. < 0.05 vs. the other 3 groups. **D <0.05
vs. C.
8%. With this criterium, Ang 11(10 nM) contracted between 40
to 57% of the cells, and this effect was prevented and reversed
by ST (1 ILM).
After finishing these morphological experiments, more than
94% of the cells excluded the trypan blue dye.
Table 1. Percentage of contracted cultured rat mesangial cells under
different experimental conditions
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Immunoblot
Fig. 5. Proteins of 32P labeled mesangial
cells were separated in SDS-PAGE and then
transferred onto nitrocellulose. The
immunostaining of these proteins with a
monoclonal antimyosin light chain antibody
gave a well defined band in the nitrocellulose
(A). The autoradiogram of these bands (B)
showed that Ang II increased the 32P
incorporation in myosin light chain (Lanes 2:
Ang Ill nM. Lanes 3: Ang 1110 nM) with
respect to the control cells (Lanes I), whereas
the preincubation with 1 M ST completely
blocked this effect (Lanes 4).
Time minutes
0 30
C 100 101±2
AngIl 100 78±5a
ST 100 102±1
ST-Ang II 100 98 3
PT+ ST-AngH 100 81
1+ ST-AngII 100 102±3
LNMA + ST-Ang II 100 98 2
DDA+ ST-AngII 100 97±3
MB+ ST-AngH 100 98±4
Results are expressed as percent of values at time 0 and are the mean
SEM of 5 experiments. Abbreviations are: C, cells with buffer only;
Ang H, angiotensin 1110 flM, ST, somatostatin 1 tM; ST-Ang II, cells
preincubated for 10 minutes with ST I M and then Ang 1110 n was
added; PT, preincubation for 18 hours with pertussis toxin 0.5 g/ml; I,
preincubation for 10 minutes with indomethacin 10 M; LNMA, prein-
cubation for 10 minutes with L-N-methyl-arginine 0.2 mM; DDA,
preincubation for 10 minutes with 2', 5'-dideoxyadenosine 0.1 ms, MB,
preincubation for 10 minutes with methylene blue 30 tM. For more
details, see Methods.
a P < 0.05 vs. time 0 and vs. the other groups.
Figure 4 shows the interactions between Ang II and ST with
respect to the 32P incorporation in a protein comigrating with
myosin light chain. As shown in both panels, Ang II increased
and ST decreased 32P incorporation to this myosin light chain-
like protein. Moreover, preincubation with ST (1 jiM, upper
panel) before the Ang II treatment as well as the addition of the
same ST concentration to cells previously incubated with Ang
II (lower panel) completely blocked the Ang TI-dependent
increased phosphorylation. Figure 5A shows the typical pattern
of immunostaining with the MLC antibody, with a single band
in SDS-PAGE. Lanes 1, 2, 3 and 4 represent, respectively,
control cells, cells incubated with 1 flM Ang 11(30 mm), cells
incubated with 10 nM Ang 11(30 mm), and cells preincubated for
10 minutes with 1 jiM ST (10 mm) and then added Ang 1110 flM
(30 mm). As shown in the autoradiogram (Fig. 5B), ST com-
pletely blocked the effect of Ang II on P incorporation in the
MLC. When considering the radioactivity in these immuno-
stained bands, corrected for proteins, 10 nM Ang II increased it
by 89 10% with respect to the control values (N = 3, P <
0.05), whereas the respective increase for the cells preincubated
with 1 jiM ST and then added 10 nii Ang II was only 9 7%
(N = 3, not statistically different from the control values).
Table 2 includes the results concerning the interactions
Time, mm
Fig. 6. Somatostatin prevented the changes induced by phorbol
myristate acetate in planar cell surface area (PCSA) of cultured rat
mesangial cells. Results are expressed as percent of the PCSA at time
0 and they are the mean SEM of 5 experiments. Abbreviations are: ST
+ PMA, cells preincubated for 10 minutes with I jiM somatostatin (ST)
and then (time 0) 300 nM phorbol myristate acetate (PMA) added; C,
cells with buffer; PMA, cells with PMA; ST. cells with somatostatin.
<0.05 vs. C, ST and ST + PMA.
between Ang II and ST in the presence of different pharmaco-
logical inhibitors. As it can be observed, the complete inhibition
induced by ST on the Ang TI-related reduction of PCSA in
cultured rat mesangial cells was completely blocked by prein-
cubation with pertussis toxin, but it was independent of the
blockade of prostanoid or nitric oxide synthesis with indo-
methacin and LNMA, respectively. Moreover, when cAMP
synthesis was blocked with DDA, or when the soluble guanyl-
ate cyclase was inhibited with MB, the inhibitory effect of ST
was still observed. Figure 6 shows the results of the incubation
of mesangial cells with PMA, with or without ST, demonstrat-
ing that this peptide also completely blocked the reduction in
PCSA induced by PMA. H202 also induced a significant reduc-
tion of mesangial cell PCSA (PCSA with respect to initial PCSA
after 30 mm, 81 3%, N = 5, P < 0.05) which was completely
Table 2. Changes in planar cell surface area (PCSA) of cultured rat
mesangial cells in different experimental conditions
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blocked by ST (PCSA with respect to initial PCSA after 30 mm,
102 2%, N = 5).
When the analysis of the changes in cross sectional areas was
performed on isolated glomeruli, results were comparable to
those of cells: the Ang II induced reduction in GCSA was
completely blocked by previous incubation with ST (Fig. 7A) or
by treatment of the Ang IT-contracted glomeruli with ST (Fig.
8A). In both cases, the effect was dose-dependent, with a
significant effect of ST at 10—8 M and a complete inhibition at
i0 M (Figs. 7 and 8B).
Table 3 includes the clearance studies in anesthetized rats.
No differences could be detected in the mean values of the three
basal experimental periods of the three groups of rats (Control
group: C1,, 0,61 0.21 mllmin, CPAH 1.87 0.41 ml/min, FF32
3%, hematocrit value 51 3%. Ang II group: C1, 0.70 0.31
mi/mm, CPAH 2.13 0.42 ml/min, FF 28 3%, hematocrit
value 48 4%. ST group: C1 0.65 0.22 mi/mm, CPAH 2.01
0.44 mllmin, FF 27 4%, hematocrit value 50 3%). Param-
eters of renal function did not change in control rats throughout
the 60 minutes after the basal period. However, Ang II infusion
induced a progressive decrease of GFR, RPF and RBF and an
increased FF which was detected from the first experimental
period after starting the infusion. ST infusion partially blocked
the Ang TI-dependent changes in renal function and, as it can be
observed by analyzing the data of experimental period 3, GFR
increased by about 25%, RPF and RBF increased by about 35%
and FF decreased by about 20% when ST was administered
during the continuous infusion of Ang II.
Discussion
The present results clearly demonstrate that ST inhibits the
reduction in PCSA and the increased MLC phosphorylation
induced by Ang IT in cultured rat mesangial cells. In other
words, ST relaxes these cells when they are contracted with
Ang II, since not only does it block the effects on PCSA, but
also the changes in MLC phosphorylation. This parallel exper-
imental approach, analyzing both morphological and biochem-
ical criteria of contraction, is very important in order to assess
the vasoactive properties of any potential modulator of mesan-
gial cell contraction, as morphological changes could not pro-
vide correct information [23, 24]. In this sense, the studies of
MLC phosphorylation with ST alone support the importance of
biochemical studies. ST reduced 32P incorporation in MLC of
mesangial cells, supporting a direct relaxing effect of the
peptide, but was unable to induce any significant change in
PCSA in these cells maintained in plastic flasks, perhaps
because under these culture conditions cells are unable to
increase their PCSA. Thus, biochemical studies must always be
performed when trying to assess the relaxant properties of any
substance on cultured mesangial cells.
Two characteristics of the ST-dependent relaxation must be
stressed. First, the effect of ST was evident both when the cells
were preincubated with the hormone and when ST was added to
the incubation media after Ang II incubation, suggesting a
A
Fig. 7. Somatostatin prevents the changes induced by angiotensin 11 in
a glomerular cross sectional area (GCSA) of isolated rat gloineruli.
Results are expressed as percent of the GCSA at time 0 and they are the
mean SEM of 5 experiments. Abbreviations are: C, glomeruli with
buffer; Ang IL, glomeruli with angiotensin II; ST, glomeruli with
somatostatin. A. ST + Ang II: Glomeruli preincubated for 10 minutes
with 1 jiM somatostatin (ST) and then (time 0) added 10 nM aflgiOteflsifl
H (Ang II). Symbols are: closed bars, time 0; hatched bars, time 30. *D
< 0.05 vs. time 0. B. glomeruli preincubated for 10 minutes with
different ST concentrations and then 10 nM Ang II added for 30 minutes.
*D < 0.05 vs. Ang II.
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Fig. 8. Somatostatin reverses the changes induced by angiotensin H in
glomerular cross sectional area (GCSA) of isolated rat glomeruli.
Results are expressed as percent of the GCSA at time 0 and are the
mean SEM of 5 experiments. Abbreviations are: C, cells with buffer;
Ang II, cells with angiotensin II; ST, cells with somatostatin. A. Ang
I1-ST: Glomeruli incubated for 30 minutes with 10 nM angiotensin II
(Ang IL) and then I somatostatin (ST) added for 30 minutes.
Symbols are: closed bars, time 0; hatched bars, time 30; open bars, time
60. *U < 0.05 vs. time 0. B. Glomerulj incubated for 30 minutes with 10
flM Ang II and then different ST concentrations added for 30 minutes.
*D < 0.05 vs. Ang II.
Table 3. Clearance studies in anesthetized rats: Interactions between
angiotensin II and somatostatin
B 1 2 3
GFR
C 100 103±4 102±2 102±5
Ang II
Ang II + ST
100
100
83 6ab
78 5ab
84 7ab
85 3& 46 9'70 8
RPF
C 100 104 7 99 3 100 7
Ang II 100 62 57 1l' 34 gab
Ang II + ST 100 73 7ab 51 6ab 67 5
RBF
C 100 100±4 93±7 98±4
Ang II 100 62 7' 69 10ab 33 9ab
Ang II + ST 100 72 7& 52 8' 66 8
FF
C 100 105±3 103±5 100±7
Ang II 100 134 12w' 146 14ab 137 9ab
Ang II + ST 100 109 I3 144 7ab 117 6
Results are expressed as percent of basal values (B) and are the mean
+ SEM of 12 rats in each experimental group. Abbreviations are: GFR,
glomerular filtration rate measured as CIN; RPF, renal plasma flow
measured as CPAH; RBF, renal blood flow; FF, filtration fraction; B,
mean of the first two 20-minute clearance periods; C, control rats; Ang
II, after B rats received 1.7 sg/min/kg body wt angiotensin II; Ang II +
ST, after B rats received 1.7 sg/min/kg body wt of angiotensin H and
after the 20-minute experimental periods 1 and 2, they received 200
ng/kg body wt as a direct injection and then 25 ng/min/kg body wt of
somatostatin.
a < 0.05 vs. Bb P < 0.05 vs. C
P < 0.05 vs. C and Ang II
preventing and a reversing role for ST on the Ang II effects,
respectively. Second, in both cases, the ST inhibitory effect
was dose-dependent, with an effective blocking concentration
of about 10 flM and over. With respect to these concentrations,
it is very difficult to extrapolate to the in vivo situation. First,
the incubation of mesangial cells in plastic culture flasks with a
selected, not completely physiological medium and at room
temperature differs significantly from the in vivo glomeruli.
Secondly, the Ang II concentration was chosen because of its
proven efficacy, and it is possible that the dose-response curve
of ST would be different with another Ang II concentration. In
any case, there was a clear inhibitory relationship between 10
flM Ang II and 10 nM ST. both at rather low concentrations,
which supports the possibility that the effect of ST may not be
only pharmacological.
To the best of our knowledge, this is the first report in the
literature describing the effects of ST on cultured rat mesangial
cells. Thus, some experimental protocols were designed in
order to start to clarify the mechanisms responsible for the
observed effects in mesangial cells. The first question to analyze
would be the presence of specific membrane receptors in
mesangial cells. Radioligand studies with labeled ST were not
performed, but Roca, Arilla and Prieto demonstrated the pres-
ence of ST receptors on the renal cortex [21, supporting the
possibility that at least part of these receptors would be in
mesangial cells. The second question to answer was the possi-
ble dependence of the observed effect of ST on the presence of
a specific G protein in the cell membranes. As shown in the
Results section, pertussis toxin blocked the relaxing effect of ST
on mesangial cells, supporting the existence of this kind of
protein. Similar proteins have been described as mediators of
C Ang II ST Ang Il-ST
B
6
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ST effects in other cellular systems such as GH4C1 cells [251. It
is thus possible that they also mediate the hormone effect in
mesangial cells. The third question to answer was whether the
effect of ST was the consequence of a direct interaction with the
cells or whether it depended on a secondary release of other
vasoactive metabolites. Mesangial cells synthesize PGE2 [261
and nitric oxide (NO) [271, both of which are relaxant mediators
[28, 29]. Thus, it could be the case that ST induce an increased
production of these metabolites which would be directly re-
sponsible for the relaxation. When PGE2 and NO synthesis
were respectively inhibited by blocking cyclooxygenase with
indomethacin [301 or NO synthetase with LNMA [311, ST was
still able to block the Ang Il-dependent contraction, thus
suggesting the independence of the ST relaxing effects of POE2
and NO synthesis.
With respect to the intracellular mechanisms of action of ST
in cultured rat mesangial cells, some preliminary information
may be obtained from the present results. ST-dependent relax-
ation was observed both in the presence and in the absence of
DDA. Since this metabolite blocks cAMP production [30], it
can be proposed that the relaxing effect of ST must not be
mediated by this cyclic nucleotide. In addition, the effect of ST
was not blocked by MB, an inhibitor of the soluble guanylate
cyclase [32], pointing to an intracellular mechanism indepen-
dent of this enzymatic system.
Although rather improbable, another possibility to account
for the ST inhibition of the Ang II effect would be a displace-
ment of the latter from its membrane receptors. No specific
radioligand studies have been performed to confirm this aspect,
but different evidences argue against this possibility. First, ST
also blocked the contractile effect of hydrogen peroxide on
cultured rat mesangial cells, an effect which seems to be
dependent on platelet-activating factor [20], and it does not
seem probable that both Ang II and platelet-activating factor act
through the same membrane receptor. Second, ST also blocked
the PMA contractile effect, and this phorbol ester obviously
acts by a mechanism independent of the Ang II membrane
receptor. Third, ST does not modify the binding of radiolabeled
Ang II in other cellular systems [33]. Thus, ST does not seem to
displace Ang II from its membrane receptor, although this
possibility cannot be completely rejected.
The results with PMA deserve special attention. The main
mechanism of contraction of mesangial cells by PMA depends
on an activation of protein kinase C (PKC) [341 with the
subsequent phosphorylation of MLC. ST blockade of the PMA-
induced contraction strongly supports an inhibitory role for ST
in the biochemical phenomena occurring after PKC activation.
The last point to be considered is the physiological meaning
of the present findings. Although this work was performed on
primary cultures, it is not possible to be completely sure that
cultured cells function as in vivo cells do. Indeed, some recent
experimental results suggest that the contractile proteins ex-
pressed by cultured mesangial cells may not be present in fresh
glomeruli or intact kidneys [35]. Thus, we performed experi-
ments in fresh, isolated rat glomeruli, and results were com-
pletely comparable to those from the cells: a prevention and a
reversion of the Ang TI-induced glomerular contraction, within
the same range of concentrations. This finding supports the
existence of some cellular intraglomerular element, with minor
phenotypic modifications with respect to the intact animal,
capable of responding to Ang II and ST; this element could be
the mesangial cell. Moreover, ST also blocked the reduction in
GFR and RPF induced by Ang II, thus giving further support to
the relaxant properties of this peptide in the presence of an
excess of vasoconstrictor substances. However, it is not pos-
sible to establish a direct correlation between in vivo and cell
effects, since clearance studies were performed only to assess
the ST inhibitory effect, without testing different infusion rates
of both Ang II and ST, and also because micropuncture studies
focusing on the different determinants of GFR were not carried
out.
In summary, these results demonstrate the relaxing effect of
ST in cultured rat mesangial cells treated with Ang II. This
effect seems to depend on the presence of a G-protein in the cell
membrane, being independent of the secondary production of
other relaxing metabolites as PGE2 or NO. These actions were
not only evident in cells, but similar results were also obtained
in isolated glomeruli and in vivo clearance studies, which
highlights the possible physiological or pathophysiological im-
portance of this peptide as a modulator of renal filtration in
situations characterized by an excess of vasoconstrictors. If we
remember the demonstration by Kurokawa et al [36] of the
presence of ST in glomerular structures, we can propose a role
for ST as a local regulatory hormone in the kidney.
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